Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers.

ABSTRACT:

Background

Many studies have shown the link between the pretreatment serum transthyretin and prognosis in gastrointestinal (GI) cancers. However, based on the conclusion, the initial findings were inconsistent. Hence, this meta-analysis was performed to identify the prognostic values of the pretreatment serum transthyretin in GI cancers.

Methods

Previous studies published before November 2018 were collected from a comprehensive literature search of several databases. The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were applied in the assessment of the intensity of associations. Also, the publication bias and the robustness of merged data were assessed. All statistical analyses were undertaken using STATA/SE 14.1.

Results

The combined data indicated t

SUBMITTER: Luo H 

PROVIDER: S-EPMC6589268 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature